Skip to Main Content
CWRU Links
Office of Research and Technology Management

Technology Validation and Start-Up Fund

Technology Validation and Start-Up Fund

CWRU Technology Validation & Start-up Fund Program ("CTP")

 

 

The CWRU Technology and Validation Start-Up Fund Program (CTP), awarded by the Ohio Third Frontier and managed through the CWRU Technology Transfer Office, aims to accelerate and fund the translation of promising technologies into the marketplace through Ohio based companies with the eventual goal of creating greater economic growth. The $500,000 fund will help faculty researchers advance and commercialize their innovations. Three rounds of funding are expected in 2017.

 

The CTP is intended to be the final bridge between a translational research project and a viable commercial program. Funding will support technologies that require validation/proof that will directly impact and enhance commercial viability and the ability to support a start-up company.

 

The two CTP award recipients for Round 1 are: 

Photo of Nicole Steinmetz

Nicole F. Steinmetz, PhD, Department of Biomedical Engineering

Plant virus-like particle (VLP)-based cancer immunotherapy 

The technology: Plant virus-like particles introduced directly into the tumor microenvironment after tumors are established act as an in situ vaccine and induce a potent, sustained, and specific anti-tumor response.

 

 

  

 

  ‌‌Photo of Susann Brady-Kalnay

Susann Brady-Kalnay, PhD, Department of Molecular Biology and Microbiology

A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors

The technology: A highly specific fluorescent biomarker used to identify glioblastoma cells not only of the primary tumor but also for diffuse secondary tumors in real-time for surgical resection.

 

 

 

 

 

 The three CTP award recipients for Round 2 are:

 

‌ Photo of Dominique Durand

Dominique Durand, PhD, Department of Biomedical Engineering

Non-Invasive Sensory Stimulation for Seizure Suppression

The technology: A non-invasive, alternative method to prevent seizures using deep brain stimulation technology.  A mask integrated with LEDs and earphones delivers low frequency stimulation through audio clicks and visual flashes to suppress seizures.

 

 

 

 Photo of Anant Madabhushi

Anant Madabhushi, PhD, Department of Biomedical Engineering

Computerized Histologic Risk Predictor (CHiRP) of benefit of adjuvant therapy in Lung Cancer

The technology: Software to predict disease recurrence in early stage lung cancer patients and help determine whether patients will benefit from adjuvant chemotherapy.

 

 ‌

 

 

 Photo of Miklos Gratzl

Miklos Gratzl, PhD, Department of Biomedical Engineering

Portable Sweat Chloride Tester For Early Diagnosis of Cystic Fibrosis

The technology: Fully automated, hand held device to diagnose Cystic Fibrosis in newborns requiring only one-tenth of the sample size required by current technologies.

 

 

 

 

 

 

The four CTP award recipients for Round 3 are:

 

Picture of Aaron Weinberg

Aaron Weinberg DMD, PhD, School of Dental Medicine

Point-of-Care Device for Diagnosis and Monitoring of Oral Cancer

The technology: A non-invasive oral cancer biomarker test thatcollects cells from questionable oral lesions and objectively determines if they are cancerous within 15 minutes.

 

  

 ‌

  

 Picture of Jerry Silver

Jerry Silver, PhD, School of Medicine

Isabelle Deschenes, PhD,  Metro Health Medical Center

IND enabling experiments for Intracellular Sigma Peptide in Acute Myocardial Ischemia

The technology: Novel therapeutic approach in the treatment of myocardial ischemia/infarction using a peptide that can regenerate cardiac nerves into the infarcted myocardium.

 

  

‌ Photo of Anant Madabhushi

Anant Madabhushi, PhD, Department of Biomedical Engineering

LunIRiS: Decision Support for Lung Cancer Screening

The technology: Image analysis software on CT scans to determine whether lung nodules are benign or cancerous to prevent unnecessary surgical interventions.

 

   

 

 

 

 ‌Picture of Andrew Rollins

Andrew M. Rollins, PhD,

OCT Image Guidance for RFA Therapy of Atrial Fibrillation

The technology: Catheter that combines Optical Coherence Tomography (OCT) with guided cardiac radiofrequency ablation therapy to provide direct visualization of critical intra-cardiac structures.